David Bray

A Randomized Placebo Controlled Clinical Trial to Determine the Impact of Digestion Resistant Starch MSPrebiotic® on Glucose, Insulin, and Insulin Resistance in Elderly and Mid-Age Adults

B. Hiebert, M. Alfa, P. Tappia, 2018, Front. Med..

A randomized trial to determine the impact of a digestion resistant starch composition on the gut microbiome in older and mid-age adults.

L. Lix, G. Van Domselaar, M. Graham, 2017, Clinical nutrition.

A saturation mutagenesis screen uncovers resistant and sensitizing secondary KRAS mutations to clinical KRASG12C inhibitors

J. Fortin, Weiru Wang, Z. Khan, 2022, Proceedings of the National Academy of Sciences of the United States of America.